The results indicate that there is a decrease in viability of glioma cells when treated with medium from SMAD4 knockdown microglial cells (Figure 6C), suggesting that suppression of SMAD4 in microglia decreases the viability of glioma cells. This evidence concerns the gene SMAD4 and central nervous system cancer.